Martine C. Apollon

Martine Apollon practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation.

Martine Apollon's NPI, 1063961605, was assigned on September 23, 2016. Martine Apollon holds Florida license ARNP9210722.

Martine Apollon's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Martine Apollon's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation. Martine Apollon is also affiliated with HCA Florida St. Lucie Hospital. The medical group on file is Cleveland Clinic Indian River Hospital. Dmand AI also links Martine Apollon to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Martine Apollon practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Martine Apollon's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Martine Apollon is licensed in Florida.

CMS data shows 234 Medicare services from Martine Apollon across 1 procedure code in 2024, for 254 Medicare patients. Medicare paid $27,476 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 254 Medicare patients who saw Martine Apollon in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Martine Apollon's median patient age at 69, with 48% women.

In 2024, Martine Apollon wrote 186 Medicare Part D claims for 21 patients. 90% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $78 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Martine Apollon for performance year 2024, reported through an alternative payment model (APM). Martine Apollon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Martine Apollon from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $139.